Treatment profile and complications associated with cryotherapy for localized prostate cancer: A population-based study

Prostate Cancer and Prostatic Diseases

Volumn 14, Issue 4, 2011, Pages 313-319

  Roberts, C B ^a   Jang, T L ^b,c,d   Shao, Yu Hsuan ^b   Kabadi, S ^e   Moore, D F ^f   Lu Yao, G L ^b,c,d,f  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d Dean and Betty Gallo Prostate Cancer Center   (United States)

^e DREXEL UNIVERSITY   (United States)

^f UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

cryotherapy; Medicare; prostatic neoplasms; Surveillance Epidemiology and End Results Program

Indexed keywords

AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; COMORBIDITY; CONTROLLED STUDY; CRYOTHERAPY; ERECTILE DYSFUNCTION; HUMAN; HYDRONEPHROSIS; INTERMETHOD COMPARISON; INTESTINAL BLEEDING; INTESTINE FISTULA; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICARE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECIPIENT; TREATMENT OUTCOME; URINARY TRACT FISTULA; URINARY TRACT OBSTRUCTION; URINE INCONTINENCE;

AGED; AGED, 80 AND OVER; CRYOTHERAPY; ERECTILE DYSFUNCTION; HUMANS; MALE; PROSTATIC NEOPLASMS; RISK FACTORS; URINARY INCONTINENCE;

EID: 80955134037     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2011.17     Document Type: Article

References (36)

1. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol 2004; 22: 2141-2149. (Pubitemid 41095147)
2. Dale W, Bilir P, Han M, Meltzer D. The role of anxiety in prostate carcinoma: a structured review of the literature. Cancer 2005; 104: 467-478. (Pubitemid 41022802)
3. Babaian RJ, Donnelly B, Bahn D, Baust JG, Dineen M, Ellis D et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 2008; 180: 1993-2004.
4. Saliken JC, Donnelly BJ, Rewcastle JC. The evolution and state of modern technology for prostate cryosurgery. Urology 2002; 60: 26-33. (Pubitemid 36153111)
5. Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll PR et al. Evaluating localized prostate cancer and identifying candidates for focal therapy. Urology 2008; 72: S12-S24.
6. Malcolm JB, Fabrizio MD, Barone BB, Given RS, Lance DF, Lynch JW et al. Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer. J Urol 2010; 183: 1822-1828.
7. Coogan CL, McKiel CF. Percutaneous cryoablation of the prostate: preliminary results after 95 procedures. J Urol 1995; 154: 1813-1817.
8. Ellis DS, Manny Jr TB, Rewcastle JC. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Urology 2007; 70: 9-15.
9. Donnelly BJ, Saliken JC, Ernst DS, Ali-Ridha N, Brasher PM, Robinson JW et al. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology 2002; 60: 645-649. (Pubitemid 35246451)
10. Aus G, Pileblad E, Hugosson J. Cryosurgical ablation of the prostate: 5-year follow-up of a prospective study. Eur Urol 2002; 42: 133-138.
11. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002; 60: 3-11. (Pubitemid 36153108)
12. Cohen JK. Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results. Urology 1996; 48: 178-180.
13. Prepelica KL, Okeke Z, Murphy A, Katz AE. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer 2005; 103: 1625-1630. (Pubitemid 40490023)
14. Long JP, Fallick ML, LaRock DR, Rand W. Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol 1998; 159: 477-484. (Pubitemid 28049259)
15. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002; 40: IV-3-IV-18.
16. Shinohara K, Connolly JA, Presti Jr JC, Carroll PR. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol 199; 15: 115-121.
17. Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. Dec 2000; 53: 1258-1267 (Pubitemid 32007842)
18. National Comprehensive Cancer Network 2010 Available at: http://www.nccn.org. Accessed (March 15, 2010).
19. Finley DS, Pouliot F, Miller DC, Belldegrun AS. Primary and salvage cryotherapy for prostate cancer. Urol Clin North Am 2010; 37: 67-82.
20. Ritch CR, Katz AE. Prostate cryotherapy: current status. Curr Opin Urol 2009; 19: 177-181.
21. Kane CJ, Lubeck DP, Knight SJ, Spitalny M, Downs TM, Grossfeld GD et al. Impact of patient educational level on treatment for patients with prostate cancer: data from CaPSURE. Urology 2003; 62: 1035-1039. (Pubitemid 37510086)
22. Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010; 28: 1117-1123.
23. Wong WS, Chinn DO, Chinn M, Chinn J, Tom WL. Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer 1997; 9: 963-974. (Pubitemid 27089880)
24. Long JP, Bahn D, Lee F, Shinohara K, Chinn Do, Macaluso Jr JN. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 2001; 57: 518-523. (Pubitemid 32192984)
25. Kimura M, Mouraviev V, Tsivian M, Moreira DM, Mayes JM, Polascik TJ. Analysis of urinary function using validated instruments and uroflowmetry after primary and salvage prostate cryoablation. Urology 2010; 76: 1258-1265.
26. Long JP. Is there a role for cryoablation of the prostate in the management of localized prostate carcinoma? Hematol Oncol Clin North Am 1996; 10: 675-690. (Pubitemid 26171137)
27. Shinohara K, Rhee B, Presti Jr JC, Carroll PR. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol 1997; 158: 2206-2210. (Pubitemid 27481358)
28. Wake RW, Hollabaugh Jr RS, Bond KH. Cryosurgical ablation of the prostate for localized adenocarcinoma: a preliminary experience. J Urol 1996; 155: 1663-1666. (Pubitemid 26126972)
29. Markland AD, Goode PS, Redden DT. Prevalence of urinary incontinence in men: results from the national health and nutrition examination survey. J Urol 2010; 84: 1022-1027.
30. Diokno AC, Estanol MVC, Ibrahim A, Balasubramaniam M. Prevlance of urinary incontinence in community dwelling men: a cross sectional nationwide epidemiological survey. Int Urol Nephrol 2007; 39: 129-136. (Pubitemid 46722954)
31. Dugan E, Roberts CP, Cohens SJ, Preisser JS, Davis CC, Bland DR et al. Why older community-dwelling adults do not discuss urinary incontinence with their primary care physicians. J AM Geriatr 2001; 49: 462-465. (Pubitemid 32390881)
32. Roehrborn CG, Boyle P, Gould AL, Waldstreicher J. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 1999; 53: 581-589. (Pubitemid 29136206)
33. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830. (Pubitemid 27246947)
34. Rhoden EL, Telöken C, Sogari PR, Vargas Souto CA. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impotence Res 2002; 14: 242-250.
35. Wei J, Dunn R, Litwin M, Sandler H, Sanda M. Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC) for Comprehensive Assessment of Health-Related Quality of Life in Men with Prostate Cancer. Urology 2000; 56: 899-905.
36. De La Taille A, Benson MC, Bagiella E, Burchardt M, Shabsigh A, Olsson CA et al. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int 2000; 85: 281-286. (Pubitemid 30088519)